Pain-resolving immune mechanisms in neuropathic pain

NT Fiore, SR Debs, JP Hayes, SS Duffy… - Nature Reviews …, 2023‏ - nature.com
Interactions between the immune and nervous systems are of central importance in
neuropathic pain, a common and debilitating form of chronic pain caused by a lesion or …

Dilated cardiomyopathy and chronic cardiac inflammation: Pathogenesis, diagnosis and therapy

D Harding, MHA Chong, N Lahoti… - Journal of internal …, 2023‏ - Wiley Online Library
Dilated cardiomyopathy (DCM) is typically defined by left ventricular dilation and systolic
dysfunction in the absence of a clear precipitant. Idiopathic disease is common; up to 50% of …

Management of immunotherapy-related toxicities, version 1.2019, NCCN clinical practice guidelines in oncology

JA Thompson, BJ Schneider, J Brahmer… - Journal of the National …, 2019‏ - jnccn.org
The aim of the NCCN Guidelines for Management of Immunotherapy-Related Toxicities is to
provide guidance on the management of immune-related adverse events resulting from …

European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa

CC Zouboulis, N Desai, L Emtestam… - Journal of the …, 2015‏ - Wiley Online Library
Hidradenitis suppurativa/acne inversa (HS) is a chronic, inflammatory, recurrent, debilitating
skin disease of the hair follicle that usually presents after puberty with painful, deep‐seated …

The cytokine storm of severe influenza and development of immunomodulatory therapy

Q Liu, Y Zhou, Z Yang - Cellular & molecular immunology, 2016‏ - nature.com
Severe influenza remains unusual in its virulence for humans. Complications or ultimately
death arising from these infections are often associated with hyperinduction of …

T cell immunobiology and cytokine storm of COVID‐19

XH Luo, Y Zhu, J Mao, RC Du - Scandinavian journal of …, 2021‏ - Wiley Online Library
Abstract 2019 coronavirus disease (COVID‐19) presents as a newly recognized pneumonia
and could rapidly progress into acute respiratory distress syndrome which has brought …

Can antinuclear antibodies have a pathogenic role in systemic sclerosis?

A Chepy, L Bourel, V Koether, D Launay… - Frontiers in …, 2022‏ - frontiersin.org
Systemic sclerosis (SSc) is a connective tissue disease characterized by extensive fibrosis
of the skin and internal organs, associated with vasculopathy and autoimmune features …

Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease

Y Rodríguez, N Vatti, C Ramírez-Santana… - Journal of …, 2019‏ - Elsevier
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an autoimmune disease
characterized by neurological symptoms and signs of progressive weakness, paresthesias …

Intravenous immunoglobulins as immunomodulators in autoimmune diseases and reproductive medicine

T Velikova, M Sekulovski, S Bogdanova, G Vasilev… - Antibodies, 2023‏ - mdpi.com
Intravenous administration of immunoglobulins has been routinely used for more than 60
years in clinical practice, developed initially as replacement therapy in immunodeficiency …

Immunomodulation as a potent COVID-19 pharmacotherapy: Past, present and future

DM Hertanto, BS Wiratama, H Sutanto… - Journal of …, 2021‏ - Taylor & Francis
In the first year of its appearance, the 2019 coronavirus disease (COVID-19) has affected
more than 150 million individuals and killed 3 million people worldwide. The pandemic has …